Literature DB >> 28987672

Volume fractions of DCE-MRI parameter as early predictor of histologic response in soft tissue sarcoma: A feasibility study.

Wei Xia1, Zhuangzhi Yan2, Xin Gao3.   

Abstract

OBJECTIVE: To find early predictors of histologic response in soft tissue sarcoma through volume transfer constant (Ktrans) analysis based on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).
MATERIALS AND METHODS: 11 Patients with soft tissue sarcoma of the lower extremity that underwent preoperative chemoradiotherapy followed by limb salvage surgery were included in this retrospective study. For each patient, DCE-MRI data sets were collected before and two weeks after therapy initiation, and histologic tumor cell necrosis rate (TCNR) was reported at surgery. The DCE-MRI volumes were aligned by registration. Then, the aligned volumes were used to obtain the Ktrans variation map. Accordingly, three sub-volumes (with increased, decreased or unchanged Ktrans) were defined and identified, and fractions of the sub-volumes, denoted as F+, F- and F0, respectively, were calculated. The predictive ability of volume fractions was determined by using area under a receiver operating characteristic curve (AUC). Linear regression analysis was performed to investigate the relationship between TCNR and volume fractions. In addition, the Ktrans values of the sub-volumes were compared.
RESULTS: The AUC for F- (0.896) and F0 (0.833) were larger than that for change of tumor longest diameter ΔD (0.625) and the change of mean KtransΔKtrans¯ (0.792). Moreover, the regression results indicated that TCNR was directly proportional to F0 (R2=0.75, P=0.0003), while it was inversely proportional to F- (R2=0.77, P=0.0002). However, TCNR had relatively weak linear relationship with ΔKtrans¯ (R2=0.64, P=0.0018). Additionally, TCNR did not have linear relationship with DD (R2=0.16, P=0.1246).
CONCLUSION: The volume fraction F- and F0 have potential as early predictors of soft tissue sarcoma histologic response.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dynamic contrast-enhanced magnetic resonance imaging; Histologic response prediction; Soft tissue sarcoma; Volume transfer constant; Voxel-wise analysis

Mesh:

Substances:

Year:  2017        PMID: 28987672     DOI: 10.1016/j.ejrad.2017.08.021

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  6 in total

1.  Pathologic necrosis following neoadjuvant radiotherapy or chemoradiotherapy is prognostic of poor survival in soft tissue sarcoma.

Authors:  Nicholas P Gannon; Matthew H Stemm; David M King; Meena Bedi
Journal:  J Cancer Res Clin Oncol       Date:  2019-03-07       Impact factor: 4.553

Review 2.  Virtual Biopsy in Soft Tissue Sarcoma. How Close Are We?

Authors:  Amani Arthur; Edward W Johnston; Jessica M Winfield; Matthew D Blackledge; Robin L Jones; Paul H Huang; Christina Messiou
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

3.  Feasibility of a multiparametric MRI protocol for imaging biomarkers associated with neoadjuvant radiotherapy for soft tissue sarcoma.

Authors:  Lucy Kershaw; Laura Forker; Darren Roberts; Benjamin Sanderson; Patrick Shenjere; James Wylie; Catherine Coyle; Rohit Kochhar; Prakash Manoharan; Ananaya Choudhury
Journal:  BJR Open       Date:  2021-12-14

4.  High-grade soft-tissue sarcoma: optimizing injection improves MRI evaluation of tumor response.

Authors:  Amandine Crombé; François Le Loarer; François Cornelis; Eberhardt Stoeckle; Xavier Buy; Sophie Cousin; Antoine Italiano; Michèle Kind
Journal:  Eur Radiol       Date:  2018-07-23       Impact factor: 5.315

5.  Soft Tissue Sarcoma Stiffness and Perfusion Evaluation by MRE and DCE-MRI for Radiation Therapy Response Assessment: A Technical Feasibility Study.

Authors:  Kay Pepin; Roger Grimm; Soudabeh Kargar; B Matthew Howe; Karen Fritchie; Matthew Frick; Doris Wenger; Scott Okuno; Richard Ehman; Kiaran McGee; Sarah James; Nadia Laack; Michael Herman; Deanna Pafundi
Journal:  Biomed Phys Eng Express       Date:  2019-05-22

6.  Potential 18F-RGD PET/CT and DCE-MRI Imaging-Based Biomarkers for Postoperative Survival Prediction Among Patients With Newly Diagnosed Glioblastoma Treated With Bevacizumab and Chemoradiotherapy.

Authors:  Li Li; Ning Liu; Hui Zhang; Rongjie Tao; Shuqiang Zhao; Zhaoqiu Chen; Zheng Fu; Wanhu Li; Liang Xu; Yuhui Liu; Jinming Yu; Shuanghu Yuan
Journal:  Front Oncol       Date:  2022-08-26       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.